Discussion Using data from the STEP 1 and STEP 2 phase 3 trials, we found broad effects from subcutaneous semaglutide treatment in people with overweight or obesity (with and without T2D) on the circulating proteome compared with placebo
Users praise the structured coaching and daily lessons, though some note that the medication side of the program feels separate from the behavior coaching at times
Cost and Access Considerations The brand you switch to (Mounjaro vs
Contact your healthcare provider if diarrhea persists beyond 2-4 weeks at a stable dose, if you experience severe or bloody diarrhea, signs of dehydration (dizziness, decreased urination, extreme thirst), severe abdominal pain, or if symptoms significantly interfere with daily activities or medication adherence
Starting with a lower dose helps your body adjust gradually, and most patients see improvements over time